Get started
Author

Alissa Looby

Observed names: A Looby, A. Looby, Looby, Alissa
ORCID: 0000-0002-7471-3439
Observed ORCID: 0000-0002-7471-3439
OpenAlex ID: A5075663807
Uncertainties in evaluating the health-related quality of life and disease burden of people with rare diseases and their caregivers in NICE HST submissions
2024 · Alissa Looby, Amy Dymond, et al. · Orphanet Journal of Rare Diseases · 8
PDF
Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trial
2025 · Thomas Gaziano, José María Castellano, et al. · The Lancet Regional Health - Europe · 4
PDF
Time trade-off study to establish utility decrements in individuals with a spinal cord injury who perform intermittent catheterization
2023 · A. Looby, H. Davies, et al. · Journal of Medical Economics · 4
PDF
Surgical antibiotic prophylaxis in women undergoing caesarean delivery: a systematic review of clinical practice guidelines
2025 · T. Wade, A. Looby, et al. · Journal of Hospital Infection · 2
HTA15 A Review of Utility Data Used in Health Technology Assessments From the Perspective of a Health Technology Assessment Body
2025 · Marina Rosca, Alissa Looby, et al. · Value in Health
HTA162 Development of an NCPE-Adjusted Base Case: Assessment and Adjustment of Applicant Base Cases From the Perspective of a Health Technology Assessment Body
2024 · E Fogarty, A Looby, et al. · Value in Health
EE615 A Cost-Effectiveness Analysis of the CNIC-Polypill Strategy, Compared to Usual Care, in Secondary Cardiovascular Prevention from a Spanish Perspective Using Data from the Secure Trial
2023 · M. Hopmans, J.M. Castellano Vázquez, et al. · Value in Health
PDF
PCR134 Uncertainties in Evaluating Patient and Caregiver Health-Related Quality of Life and Disease Burden in NICE HST Submissions
2022 · A Looby, A Dymond, et al. · Value in Health
PDF
Works count: 13
Citation count: 18
H-index: 3
I10-index:
Year
Topic
Type